Literature DB >> 2921288

The metabolic effects of mild hypothermia on global cerebral ischemia and recirculation in the cat: comparison to normothermia and hyperthermia.

M Chopp1, R Knight, C D Tidwell, J A Helpern, E Brown, K M Welch.   

Abstract

The metabolic effects of graded whole body hypothermia on complete global cerebral ischemia and recirculation was investigated in the cat. Hypothermia was induced to one of three levels prior to ischemia; T = 26.8 degrees +/- 0.5 degrees C (n = 4), T = 32.1 degrees +/- 0.2 degrees C (n = 5), and T = 34.6 degrees +/- 0.3 degrees C (n = 6), and maintained constant throughout 16 min of ischemia and 1.5-2 h of recirculation. Intracellular cerebral pH and relative concentrations of high-energy phosphate metabolites were continuously monitored, using in vivo 31P nuclear magnetic resonance (NMR) spectroscopy. Except for the first 4 min of ischemia, no significant differences were detected in the response of adenylate intensities and intracellular pH to ischemia and recirculation between the hypothermic groups. The three hypothermic groups were then pooled into one group, and the data compared to previously published data from a normothermic group, T = 38.4 degrees +/- 0.6 degrees C (n = 14), and a hyperthermic group, T = 40.6 degrees +/- 0.2 degrees C (n = 9), subjected to the identical ischemic and NMR measurement protocols. The hypothermic animals exhibited a statistically significant reduction of cerebral intracellular acidosis, both during ischemia and recirculation, as well as a more rapid return of adenylate intensities during recirculation, compared to the normothermic or hyperthermic groups. The data thus suggest that mild hypothermia has an ameliorative affect on brain energy metabolism and intracellular pH under conditions of complete global cerebral ischemia and recirculation.

Entities:  

Mesh:

Year:  1989        PMID: 2921288     DOI: 10.1038/jcbfm.1989.21

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  24 in total

Review 1.  Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

2.  Successful cardiopulmonary resuscitation following cardiac arrest in a hypoglycemic cat.

Authors:  Fergal M McDermott; Kerrie A Lewis
Journal:  Can Vet J       Date:  2020-02       Impact factor: 1.008

Review 3.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

4.  Post-stroke hypothermia provides neuroprotection through inhibition of AMP-activated protein kinase.

Authors:  Jun Li; Sharon Benashski; Louise D McCullough
Journal:  J Neurotrauma       Date:  2011-06-01       Impact factor: 5.269

5.  Hypothermic cardiopulmonary bypass--time for a more temperate approach.

Authors:  J M Murkin
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

6.  Cerebral perfusion and hypothermia.

Authors:  F H Kern; W J Greeley
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

7.  Heating of the brain to maintain normothermia during ischemia aggravates brain injury in the rat.

Authors:  T Miyazawa; P Bonnekoh; R Widmann; K A Hossmann
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Neuronal damage, glial response and cerebral metabolism after hypothermic forebrain ischemia in the rat.

Authors:  H Chen; M Chopp; Q Jiang; J H Garcia
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  The effect of hypothermia on induction of heat shock protein (HSP)-72 in ischemic brain.

Authors:  K Kumar; X Wu; A T Evans; F Marcoux
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

Review 10.  Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.